Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma (RIST-rNB-2011)

Chief Investigator: Selim Corbacioglu

Sponsor: University of Regensburg

This study aims to improve the outcome of patients with relapsed or refractory neuroblastoma.

Further details about the trial can be found at clinicaltrials.gov database: https://clinicaltrials.gov/ct2/show/NCT01467986